跳至主要内容
临床试验/NCT05463614
NCT05463614招募中不适用

Population Pharmacokinetics of Propafenone and Propranolol in Children Patients

Shandong University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2019年2月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Ventricular premature beats of 24 hours

研究概览

简要总结

The use of propafenone and propranolol in children during clinical treatment was depending mostly on experience. Besides, there was no recommended dose for children in drug instruction. Therefore, the investigators' aim is to study the pharmacokinetics and pharmacodynamics in children.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged ≤18years. Parental written consent to participate in the study. Patients treat with Propafenone and Propranolol

排除标准

  • Patients can not complete the research; Abnormal hepatic and renal function; Patient is allergic to propafenone; There are conditions that researchers do not consider it appropriate to join the research.

结局指标

主要结局

Ventricular premature beats of 24 hours

时间窗: From date of randomization until the date of discharge, assessed up to 12 months

frequency of Ventricular premature beats of 24 hours

次要结局

  • P-R interval(From date of randomization until the date of discharge, assessed up to 12 months)
  • QT interval(From date of randomization until the date of discharge, assessed up to 12 months)

研究者

发起方
Shandong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Zhao

professor

Shandong University

研究点 (1)

Loading locations...

相似试验